ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MD vs SGRY // 10Y YIELD & FRED MACRO BETA

Pediatrix Medical Group Inc. (NYSE) VS. Surgery Partners Inc. (NASDAQ) • 15-METRIC TALLY: MD 4 — SGRY 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MD VS. SGRY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MD SGRY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 33.60% 9.90% +23.70 MD /roic <GO>
EV/EBITDA & P/E Valuation 9.6x 9.7x -0.10 MD /valuation <GO>
Free Cash Flow Yield 11.43% 6.44% +4.99 MD /fcf-yield <GO>
Operating Margin — 45.80% — TIE /operating-margins <GO>
Net Profit Margin — -9.20% — TIE /net-margins <GO>
Revenue Growth (YoY) — 6.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.67 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 SGRY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.3 86.2 -18.90 SGRY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.99 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 13.3x 22.0x -8.70 MD /forward-pe <GO>
Enterprise Scale & Market Cap $2.33B $3.04B -$708.9M SGRY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MD REV SGRY REV MD GROSS % SGRY GROSS % MD FCF SGRY FCF
FY 2025 $584.7M $1.09B — — $271.1M $195.6M
FY 2024 $192.4M $976.6M — — $206.6M $209.7M
FY 2023 $20.5M $918.4M — — $137.3M $293.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MD // BETA —
SGRY // BETA 0.99